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Background: We examined mortality risk in relation to presence and extent of non-obstructive coronary artery disease (CAD), as defined by a 
<50% luminal diameter stenosis and identified by 64-detector row coronary computed tomographic angiography (CCTA).
Methods: We prospectively evaluated 18,037 consecutive adults from 12 centers in 6 countries undergoing clinically-indicated 64-detector row 
CCTA without obstructive CAD (≥50%) by CCTA. Coronary artery segments were graded as having CAD (1-49% luminal diameter stenosis) versus not 
having CAD (0% luminal diameter stenosis). Events occurring <90 days after the index test were censored.
Results: During a median 2.1(interquartile range 1.5-3.1) year follow-up period, 178 deaths occurred (0.99%). Adjusted for typicality of angina 
and Framingham risk score (FRS), individuals with non-obstructive CAD experienced a more than 2-fold higher mortality as compared to individuals 
without CAD (HR 2.14, 95% CI 1.46-3.14, p<0.0001). Increased risk of mortality was observed for individuals with 2-vessel (HR 3.09, 95% CI 1.94-
4.93, p<0.0001) and 3-vessel non-obstructive CAD (HR 3.02, 95% CI 1.73-5.27, p<0.0001), with an independent linear increase in mortality for 
every additional coronary segment with CAD (HR 1.17, 95% CI 1.10-1.25, p<0.001).
Higher mortality for any non-obstructive CAD was observed even amongst patients judged low risk by FRS (HR 4.40 (95% CI 2.68-7.22), p<0.0001); 
as well as amongst those with no traditional medically-treatable CAD risk factors [i.e., diabetes, hypertension, and dyslipidemia] (HR 3.20, 95% CI 
1.57-6.50, p=0.001). Importantly, patients without any CAD experienced a very low rate of death over the entire follow-up period (annualized 0.27% 
morality).
Conclusions: Presence and extent of non-obstructive CAD augments prediction of individuals at risk of death.
